Skip to main content

68th Annual Scientific Meeting (AHS 2026) Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Red Recording

Sig Meeting

Browse by Poster Title

Browse by Poster Title

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#

S
T 42
Safety and Effectiveness of a Novel Implantable Neurostimulator for the Prevention of Resistant Migraine at 24 Months.

Favorite
T 10
Safety and Tolerability of Anti-PACAP Monoclonal Antibody Lu AG09222 when Co-administered with a Gepant in Participants with Migraine

Favorite
T 23
Safety, tolerability, and pharmacokinetics of PRT-064040 nasal spray following single and multiple ascending doses in healthy adults: a phase 1 study

Favorite
CR 19
Secondary hemicrania continua caused by idiopathic orbital inflammation

Favorite
TR 10
Serum Inflammatory Markers in Chronic versus Episodic Migraine: A Systematic Review and Meta-analysis

Favorite
CR 22
Sex-related thunderclap headache after exposure to Vonoprazan: A case report and review of literature

Favorite
TR 14
Sex-stratified genome-wide analyses of migraine uncover genetic links to cardiovascular disease, female-specific traits, and approved medications

Favorite
T 57
Sleep Disorders in Primary Headache: A Systematic Review and Meta-Analysis of Prevalence, Bidirectional Relationships, and Sleep-Targeted Intervention Efficacy

Favorite
E 32
Spoken Language and Limited English Proficiency as a Barrier to Care for the Acute Treatment of Migraine: Results from a Cross-Institutional Electronic Health Record

Favorite
CR 15
Spontaneous Intracranial Hypotension Presenting as Status Migrainosus in an Adolescent With Discordant Brain MRI Findings

Favorite
O 2
Stroke Risk Associated With CGRP Pathway Inhibitors in Adults With Migraine: Systematic Review and Meta-analysis of Randomized Trials

Favorite
CP 2
SUNCT After Traumatic Brain Injury Initially Misdiagnosed as Trigeminal Neuralgia

Favorite
T 19
Symbravo® (MoSEIC(TM) meloxicam and rizatriptan) for the Acute Treatment of Migraine: Post-hoc Composite Efficacy and Return to Function Endpoint Analysis from MOMENTUM

Favorite
T 33
Symbravo® (MoSEIC(TM) meloxicam and rizatriptan) for the Acute Treatment of Migraine: Post-hoc Composite Efficacy and Safety Endpoint Analysis of INTERCEPT and MOMENTUM

Favorite
T 30
Symbravo® (MoSEIC(TM) Meloxicam and Rizatriptan) for the Treatment of Migraine: Sustained Pain Relief and Pain Freedom Among 2-Hour Responders in the Phase 3 MOMENTUM and MOVEMENT Trials

Favorite
T 92
Symptom response to multiple epidural patches in patients with orthostatic headaches and no radiographic signs of spontaneous intracranial hypotension

Favorite
CP 12
Symptomatic low force head trauma and hypermobility

Favorite
PC 8
Synergistic antimigraine effects of combined vascular and neural targeting with lisinopril and memantine: preclinical support for clinical translation

Favorite